Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 7 to 11, 2022. This …
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
Step was taken after Pfizer notified the agency it would like to wait until data are available on a three-dose regimen
Adverse Events After BNT162b2 Do Not Differ for Cancer Patients
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment
Homologous, Heterologous COVID-19 Boosters Are Immunogenic
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by factor of 4 to 73 for all combinations
CDC Backs Full Approval of Moderna COVID-19 Vaccine
Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 31 to Feb. 4, 2022. …
COVID-19 mRNA Vaccination Does Not Impair IVF Outcomes
No association seen between vaccine administration and fertilization rates or early pregnancy outcomes
Risk for Breakthrough SARS-CoV-2 Infection Lower With mRNA-1273
Risk for breakthrough infection and of 60-day hospitalization significantly lower for mRNA-1273 versus BNT162b2 vaccination
Pfizer Asks FDA to Approve Its Vaccine for the Youngest Children
An FDA advisory panel will weigh the two-dose regimen on Feb. 15
Intention to Receive COVID-19 Vaccine Has Grown Faster Among Black Adults
Persistent lower vaccination rate in Black adults might be explained by other factors besides hesitancy